Agilon Health, Inc. · NYSE:AGL

Agilon Health — Investor Presentation (September 2023)

24 slides from Agilon Health's investor presentation, September 2023

  1. Slide 1: Investor Presentation September 2023

    Investor Presentation. September 2023 Copyright © 2023 agilon health

  2. Slide 2: Disclaimers and Forward-Looking Statements

    Disclaimers and Forward-Looking Statements FORWARD-LOOKING STATEMENTS AND OTHER INFORMATION Statements in this presentation that are not historical factual statements are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the

  3. Slide 3: Investment Highlights

    Investment Highlights Large, Growing First Mover Long-Term Alignment with Addressable Market Advantage Local Physician Leaders Unlocking Diverse Physicians & Patients Efficient Geographies & Partners Are Winning Growth Model 3

  4. Slide 4: Primary Care Economics and Capacity Are Getting Worse

    Primary Care Economics and Capacity Are Getting Worse Challenged Primary Care PCP Economics 20%+ Decline Capacity is Strained in PCP Economics 50% for Medicare 100% ~10–20% % Change Since 2001 30% Projected 50% Shortage by 2030 10% 0% (10%) 2001 2006 2011 2016 2022 2022 2024 2026 2028 2030 Physician

  5. Slide 5: While Senior Patient Outcomes Are Poor and Highly Variable

    While Senior Patient Outcomes Are Poor and Highly Variable Variation in Preventative Services Variation in Cost & Utilization <19 19 28 35 44+ AWV Completion Rate (%) ~ 2X Variation in Medicare spending across regions Uncoordinated ~ 3X & Fragmented Variation in Medicare inpatient days across region

  6. Slide 6: System is Asking More of Primary Care Doctors

    System is Asking More of Primary Care Doctors Growing Senior Population Increasing Medicare Population 2020–2030 Focus on Value 75M 100% 62M CMS target for Medicare 2020 2030 beneficiaries in total cost models by 2030 Copyright © 2023 agilon health 6

  7. Slide 7: We Are Solving That Problem & Creating a Better Health Care System

    We Are Solving That Problem & Creating a Better Health Care System agilon’s Total Care Model Driving Consistent Results Patient Access Quality Utilization STARs Performance by Market Class Readmissions 17.4% 12.4% 79% 4.5 Class of 2018 Readmission Rate Class of 2019 4.3 Class of 2020 Hospital Admiss

  8. Slide 8: agilon Platform Enables PCPs to Extend Reach Beyond the Four Walls of their Office

    agilon Platform Enables PCPs to Extend Reach Beyond the Four Walls of their Office Lower Performing PCPs in 2020 Pharmacist Care Manager 100% 2020 HbA1C Gap Closure Rate (%) 90% Lost to Change in 80% Follow-Up Health Plan 70% 60% 50% 40% 30% 20% 10% 0% Homebound 0% 20% 40% 60% 80% 100% Patients Card

  9. Slide 9: agilon is Improving Diabetic Eye Screening Rates and A1c Control Faster

    agilon is Improving Diabetic Eye Screening Rates and A1c Control Faster Than Both FFS and MA Improving Diabetes Eye Exam Screening Rates and Diabetes A1c Control Eye Exam for Patients with Diabetes Hemoglobin A1c Control for Patients with Diabetes 90% 90% 88% agilon % agilon 85% improvement in eye e

  10. Slide 10: Quality Improvements Translate into Lower Utilization and Cost of Care

    Quality Improvements Translate into Lower Utilization and Cost of Care Better Patient Outcomes Acute Inpatient Admits per Thousand Total Medical Expense Per Member Per Month Uncontrolled 200 ’20 &’21 183 Patients with consistent 157 $698 HbA1c control 153 150 cost 19% less Controlled than patients w

  11. Slide 11: Performance is Driving Growth

    Performance is Driving Growth Expect to Add >145K New MA Members to Platform in 2024 Markets PCPs on Platform (live and implementing) 2,700+ 32 2,200+ ~60% 25 Invest More CAGR 1,600+ 17 1,190 PCPs Join in Care 980 11 785 agilon Delivery 8 Network 2 4 2018 2019 2020 2021 2022 2023G 2024P 2018 2019 20

  12. Slide 12: Growth Drives Scale

    Growth Drives Scale Our Platform is the Solution for PCPs in VBC agilon Network: 32 Markets in 14 States In-Market TAM: Minnesota • Twin Cities Michigan • Traverse City Ohio • Columbus Maine • Portland Competitive Moat: • Lewiston 10.5M Seniors • Grand Rapids • Detroit • Akron • Zanesville • Bangor

  13. Slide 13: agilon health Economic Model & Key Attributes

    agilon health Economic Model & Key Attributes Illustrative Economic Model Key Attributes ~$900 PMPM Long-Term • 20-year joint venture partnerships Partnership • Shared economics with PCP partners High • Recurring per member revenue Visibility • 12+ Month Visibility to New Members ~$150-200+ PMPM (Ma

  14. Slide 14: High Confidence and Visibility in Long-Term Value Drivers

    High Confidence and Visibility in Long-Term Value Drivers Visibility and Confidence Has Strengthened Since 2021 Putting More Medical Margin Membership Operating Members on the Progression by Vintage Leverage at Platform Markets and (Time on Platform) Market and Member Cohorts Corporate Copyright © 2

  15. Slide 15: Membership Growth is Accelerating, Early Growth Matters

    Membership Growth is Accelerating, Early Growth Matters Markets Member Additions Members 32 Medicare Advantage (MA) Medicare Advantage (MA) ACO REACH / Direct Contracting ~170K ACO REACH / Direct Contracting ~670K 25 ~144K ~60% CAGR >145K ~501K 122K 17 107K ~50% CAGR 360K 11 84K 238K 550K 8 414K 41K

  16. Slide 16: Consistent Medical Margin Progression Across Member Cohorts

    Consistent Medical Margin Progression Across Member Cohorts Medical Margin PMPM by Member Cohorts 2018 Members 2019 Members 2020 Members 2021 Members 2022 Members $228 $209 $205 $170 $164 $145 $133 $133 $138 $96 $116 $97 $85 ~50% of Medical $37 Margin Reinvested Into Local Primary Care $45 2018 2019

  17. Slide 17: Consistent Medical Margin Progression Across Market Classes

    Consistent Medical Margin Progression Across Market Classes Medical Margin PMPM by Market Class Membership CAGR by Market Class Class of 2018 Class of 2019 Class of 2020 Class of 2021 Class of 2022 Class of 2023 2018: 11% $201 $204 2020: 14% $200 2019: 23% $142 $146 $143 $148 2021: 11% $132 $123 $13

  18. Slide 18: Member Vintage & Operating Leverage Support Margins Gains

    Member Vintage & Operating Leverage Support Margins Gains Weighted Average Market Vintage Platform Support Leverage (% of Total Revenue) 4.7 11.2% 4.1 3.5 3.3 3.3 8.2% 3.1 2.6 6.7% 2.1 5.4% ~4% ~3.5% ~3% <3% 2019 2020 2021 2022 2023P 2024P 2025P 2026P 2019 2020 2021 2022 2023P 2024P 2025P 2026P Note

  19. Slide 19: Inflecting Revenue Growth and Margins

    Inflecting Revenue Growth and Margins Revenue Medical Margin $4,525M- $4,540M $500M- $530M >50% $2,708M CAGR ~60% $305M CAGR $1,834M +71% +69% YoY YoY $182M $1,218M $1,149M $138M $794M $670M $82M $475M $54M $63M 2018 2019 2020 2021 2022 2023G 2Q22 2Q23 2018 2019 2021 2022 2023G 2Q22 2Q23 Note: Medic

  20. Slide 20: Balance Sheet Capital Deployment

    Balance Sheet Capital Deployment Expect to Generate Positive Cash from Operations in 2024 Balance Sheet & Cash Flow ~$600M of cash and marketable Anticipate significant cash flow Independent of external funding securities of September 30, generation 2024+ for achieving growth 2023 Capital Deployment

  21. Slide 21: Appendix

    Appendix Copyright © 2023 agilon health 21

  22. Slide 22: Financial Outlook for 3Q 2023 and Fiscal Year 2023

    Financial Outlook for 3Q 2023 and Fiscal Year 2023 Quarter Ending Year Ending September 30, 2023 December 31, 2023 410,000 – 413,000 412,000 – 415,000 Medicare Advantage Members 85,000 – 90,000 85,000 – 90,000 ACO REACH Members 495,000– 503,000 497,000-505,000 Total Members Live on Platform 413,000–

  23. Slide 23: Non-GAAP Reconciliations: Adjusted EBITDA

    Non-GAAP Reconciliations ADJUSTED EBITDA (Dollars in thousands) Year Ended December 31, 2022 2021 2020 2019 2018 Net income (loss)(1) ($106,864) ($406,787) ($60,052) ($282,588) ($146,926) (Income) loss from discontinued operations, net of income taxes (465) 1,303 (3,156) 168,285 65,338 Interest expe

  24. Slide 24: Non-GAAP Reconciliations: Medical Margin

    Non-GAAP Reconciliations Medical Margin (Dollars in thousands) Year Ended December 31, Three Months Ended June 30, 2022 2021 2019 2018 2023 2022 Gross profit(1) $ 112,286 $ 76,413 $ 28,511 $ 28,066 $ 57,193 $ 33,914 Other operating revenue (3,815) (3,824) (5,845) (8,215) (2,008) (950) Other medical

agilon health — Investor Presentation (September 2023) on 6ix